Valuation Active Biotech AB Nasdaq Stockholm
Stocks
ACTI
SE0001137985
Biotechnology & Medical Research
|
Real-time Estimate
Cboe Europe
10:16:00 24/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.143 SEK | +0.68% |
|
-0.83% | -9.46% |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 108.5 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | -10.54% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 108.5 | 108.5 | 108.5 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | -10.54% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -6.61x |
| EV / Revenue | - | - | - | - | - | - | - | -6.61x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -3.12x | 6.53x | 2.16x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.27x | 5.96x | 2.09x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 4.115 | 4.115 | 4.115 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 3/25/22 A | 2/9/23 A | 2/8/24 A | 2/13/25 A | 4/1/26 A | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.81x | 7.74x | 15.55x | 1.36% | 74.18B | |
| 30.94x | 8.91x | 27.77x | 0.04% | 59.55B | |
| -72.24x | 13.96x | -67.31x | -.--% | 25.84B | |
| -15.16x | 5.72x | -7.19x | -.--% | 24.73B | |
| 28.65x | 5.38x | 17.91x | -.--% | 20.87B | |
| 44.32x | 16.25x | 32.97x | 0.34% | 15.32B | |
| 17.52x | 5.22x | 12.18x | -.--% | 14.06B | |
| -14.32x | 3225.89x | -16.49x | -.--% | 13.12B | |
| -81.25x | 7.42x | -61.47x | -.--% | 11.85B | |
| Average | -4.41x | 366.28x | -5.12x | 0.19% | 28.84B | |
| Weighted average by Cap. | 6.13x | 171.32x | 3.83x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
